All terms in GO
| Label | Id | Description |
|---|---|---|
| eye morphogenesis | GO_0048592 |
The process in which the anatomical structures of the eye are generated and organized.
|
| GO_0048590 | GO_0048590 | |
| GO_0048595 | GO_0048595 | |
| embryonic camera-type eye morphogenesis | GO_0048596 |
The process in which the anatomical structures of the eye are generated and organized during embryonic development.
|
| embryonic eye morphogenesis | GO_0048048 |
The process occurring in the embryo by which the anatomical structures of the post-embryonic eye are generated and organized.
|
| camera-type eye morphogenesis | GO_0048593 |
The process in which the anatomical structures of the eye are generated and organized. The camera-type eye is an organ of sight that receives light through an aperture and focuses it through a lens, projecting it on a photoreceptor field.
|
| GO_0048594 | GO_0048594 | |
| 3-methylbut-2-enoyl-CoA(4-) biosynthetic process | GO_1902200 |
The chemical reactions and pathways resulting in the formation of 3-methylbut-2-enoyl-CoA(4-).
|
| negative regulation of bacterial-type flagellum-dependent cell motility | GO_1902201 |
Any process that stops, prevents or reduces the frequency, rate or extent of bacterial-type flagellum-dependent cell motility.
|
| regulation of hepatocyte growth factor receptor signaling pathway | GO_1902202 |
Any process that modulates the frequency, rate or extent of hepatocyte growth factor receptor signaling pathway.
|
| negative regulation of hepatocyte growth factor receptor signaling pathway | GO_1902203 |
Any process that stops, prevents or reduces the frequency, rate or extent of hepatocyte growth factor receptor signaling pathway.
|
| positive regulation of hepatocyte growth factor receptor signaling pathway | GO_1902204 |
Any process that activates or increases the frequency, rate or extent of hepatocyte growth factor receptor signaling pathway.
|
| regulation of interleukin-2-mediated signaling pathway | GO_1902205 |
Any process that modulates the frequency, rate or extent of interleukin-2-mediated signaling pathway.
|
| negative regulation of interleukin-2-mediated signaling pathway | GO_1902206 |
Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-2-mediated signaling pathway.
|
| positive regulation of interleukin-2-mediated signaling pathway | GO_1902207 |
Any process that activates or increases the frequency, rate or extent of interleukin-2-mediated signaling pathway.
|
| positive regulation of cytokine-mediated signaling pathway | GO_0001961 |
Any process that activates or increases the frequency, rate or extent of a cytokine mediated signaling pathway.
|
| regulation of bacterial-type flagellum assembly | GO_1902208 |
Any process that modulates the frequency, rate or extent of bacterial-type flagellum assembly.
|
| regulation of cell projection assembly | GO_0060491 |
Any process that modulates the rate, frequency, or extent of cell projection assembly.
|
| negative regulation of bacterial-type flagellum assembly | GO_1902209 |
Any process that stops, prevents or reduces the frequency, rate or extent of bacterial-type flagellum assembly.
|
| axonemal central pair | GO_0097540 |
Part of the axoneme consisting of the inner two microtubule doublets of the 9+2 axoneme occurring in most motile cilia.
|